February 26, 2018 / 1:20 PM / 8 months ago

BRIEF-Endocyte And ITM Announce Supply Agreement

Feb 26 (Reuters) - Endocyte Inc:

* ENDOCYTE AND ITM ANNOUNCE SUPPLY AGREEMENT FOR NO-CARRIER-ADDED LUTETIUM FOR THE PHASE 3 VISION TRIAL

* ENDOCYTE INC - UNDER SUPPLY AGREEMENT, ITM TO SUPPLY TO CO, MEDICAL RADIOISOTOPE NO-CARRIER-ADDED LUTETIUM, ENDOLUCINBETA

* ENDOCYTE INC - PHASE 3 VISION TRIAL EXPECTED TO BE INITIATED BY ENDOCYTE IN Q2 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below